Korea emerging as global drug trial hub

Published: 2012-09-25 06:59:00

Updated: 2012-09-25 06:59:00

Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research, Kim Jon-ran, Vice President of ICON plc, said in a recent interview with Yakup Shinmoon.

“These clinical trials provide enormous benefits to Korea,” said Kim.

“They benefit Korean patients, Korean medical institutions and cl...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.